Folate



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Supplementation Therapy 21.2%
Drug Exposure During Pregnancy 14.1%
Pancreatitis 12.2%
Sedation 6.4%
Hypertension 5.1%
Constipation 3.8%
Pain 3.8%
Product Used For Unknown Indication 3.8%
Thrombosis Prophylaxis 3.8%
Withdrawal Syndrome 3.8%
Alcohol Withdrawal Syndrome 3.2%
Viral Infection 3.2%
Dyspnoea 2.6%
Nausea 2.6%
Prophylaxis 2.6%
Prophylaxis Against Gastrointestinal Ulcer 2.6%
Cardiac Arrest 1.3%
Computerised Tomogram 1.3%
Endoscopy Upper Gastrointestinal Tract 1.3%
Hyperglycaemia 1.3%
Pelvic Kidney 11.1%
Polydactyly 11.1%
Productive Cough 11.1%
Renal Tubular Necrosis 11.1%
Toxic Epidermal Necrolysis 11.1%
Acute Respiratory Distress Syndrome 5.6%
Asthma 5.6%
Cryptorchism 5.6%
Drug Exposure During Pregnancy 5.6%
Foetal Exposure During Pregnancy 5.6%
Lower Respiratory Tract Infection 5.6%
Rhabdomyolysis 5.6%
Temperature Regulation Disorder 5.6%
Concomitant
Product Used For Unknown Indication 22.0%
Drug Use For Unknown Indication 19.9%
Rheumatoid Arthritis 11.9%
Hiv Infection 7.9%
Hypertension 6.2%
Chronic Obstructive Pulmonary Disease 4.0%
Paroxysmal Nocturnal Haemoglobinuria 3.6%
Crohn's Disease 3.0%
Prophylaxis 2.6%
Multiple Myeloma 2.5%
Pain 2.0%
Gastrooesophageal Reflux Disease 1.9%
Depression 1.9%
Anxiety 1.7%
Vitamin Supplementation 1.7%
Diabetes Mellitus 1.6%
Colitis Ulcerative 1.5%
Multiple Sclerosis 1.4%
Inflammatory Bowel Disease 1.4%
Osteoporosis 1.4%
Vomiting 12.8%
Pneumonia 7.5%
Upper Respiratory Tract Infection 7.1%
Urinary Tract Infection 6.2%
Thrombocytopenia 5.8%
Weight Decreased 5.8%
Progressive Multifocal Leukoencephalopathy 4.9%
Weight Increased 4.9%
Pregnancy 4.4%
Septic Shock 4.4%
Stillbirth 4.4%
Renal Failure 4.0%
Renal Failure Acute 4.0%
Crohn's Disease 3.5%
Drug Exposure During Pregnancy 3.5%
Pancytopenia 3.5%
Sepsis 3.5%
Tachycardia 3.5%
Chronic Obstructive Pulmonary Disease 3.1%
Polyarthritis 3.1%